Presbyopia Eye Drops: Pilocarpine and Aceclidine Explained

Presbyopia Eye Drops: Pilocarpine and Aceclidine Explained

Last updated: October 2026

Eye drops for presbyopia went from idea to prescription in four years. Three products are now FDA-approved, and a pilocarpine drop reached the Indian market amid controversy. Patients will ask whether they can "throw away their reading glasses", so residents need to know how these drops work, how well, and who should avoid them.

How a drop can help near vision

  • Pinhole effect: constricting the pupil increases depth of focus, so near objects come into focus without changing the lens. This works best below about a 2 mm pupil.
  • Ciliary effect: pilocarpine also contracts the ciliary muscle, adding some accommodation but also a myopic shift and brow ache.
  • Pupil-selective miotics: aceclidine acts mainly on the iris sphincter with minimal ciliary stimulation. It gives a small pupil without a meaningful myopic shift, so distance vision is preserved.

The approved drops

Pilocarpine 1.25% (Vuity)Pilocarpine 0.4% (Qlosi)Aceclidine 1.44% (Vizz)
FDA approvalOctober 2021October 2023July 2025
MechanismMuscarinic agonist acting on iris and ciliary muscleLow-dose pilocarpine, preservative-freePredominantly pupil-selective miotic
Pivotal trialsGEMINI 1 and 2: significant gain of at least 3 lines of near vision in low light at day 30, hour 3, without losing more than 1 line of distance visionNEAR-1 and NEAR-2 (600+ patients): significant gain of at least 3 lines of distance-corrected near vision without losing distance visionCLARITY 1 and 2 (n=466, 42 days); CLARITY 3 (6-month safety)
Onset and durationAbout 15 minutes, lasting up to about 6 hoursAbout 20 minutes, lasting up to about 8 hours. Can be used up to twice daily.Within 30 minutes, lasting up to about 10 hours
Common side effectsHeadache, ocular rednessHeadache 6.8%, instillation pain 5.8%Instillation irritation 20%, dim vision 16%, headache 13%

The Indian story: PresVu

A pilocarpine 1.25% drop (PresVu, Entod Pharmaceuticals) received approval from the Drugs Controller General of India in 2024. In September 2024 the regulator suspended its manufacturing and marketing permission, citing promotional claims, such as removing the need for reading glasses, that went beyond what was approved. The company challenged the order. Check its current status before advising patients, and use the episode as a lesson in matching expectations to evidence.

Choosing patients and keeping them safe

  • Best candidates: early to moderate presbyopes (roughly 40–55 years), emmetropic or low hyperopic, who want occasional spectacle independence. They are not a substitute for reading glasses in advanced presbyopia.
  • Examine the peripheral retina first. Miotics have rarely been associated with retinal tears and detachment. Be cautious in high myopes, patients with lattice degeneration or previous detachment, and anyone with flashes or floaters. Tell patients to seek care urgently for new flashes, floaters or a curtain.
  • Night driving: a small pupil dims vision in low light. Advise against driving at night or operating machinery until vision is clear.
  • Avoid or take care with iritis or uveitis, and with anatomically narrow angles (miotics can rarely worsen pupil block).
  • Practicalities: remove contact lenses before instilling, and separate from other drops by at least 5 minutes.

Viva pearls

  • Pilocarpine causes miosis plus accommodation (myopic shift). Aceclidine causes miosis without much accommodation.
  • The pinhole effect becomes useful at pupil diameters under about 2 mm.
  • Other near-vision options to compare: monovision contact lenses or surgery, multifocal and EDOF IOLs, corneal inlays (largely abandoned), and presbyopic LASIK profiles.
  • Remember the warnings: retinal detachment (rare), poor dim-light vision, brow ache.

Related: refractive surgery for residents, monovision in cataract surgery and IOL types.

Key sources

📘 Want more exam-ready material? See Most Commons in Ophthalmology on Kindle, or browse all my books.

Written by Dr. Dhaval Patel, MD (Ophthalmology, AIIMS New Delhi)

Consultant, Cataract & Refractive Surgery — among a small number of AIIMS-trained ophthalmologists practicing in Gujarat. Read full credentials & experience or view his 28 publications on ResearchGate.

📚 Also the author of OKAT Decoded and other high-yield ophthalmology exam-prep books used by residents and PG aspirants.

Looking for an eye specialist in Ahmedabad? Read our guide to spectacle lenses for near vision or book a consultation with Dr. Dhaval Patel.